Skip to content

Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01180803
Enrollment
200
Registered
2010-08-12
Start date
2010-07-31
Completion date
2023-12-31
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LUNG DISEASES, OBSTRUCTIVE

Keywords

COPD - long term oxygenotherapy, COPD patients with respiratory failure

Brief summary

The purpose of this study is to compare the efficacy of oxygen therapy delivered by systems using oxygen-saving valves or not (continuous oxygen). We aim to determine if systems using oxygen-saving valves are equally effective as continuous oxygen delivery systems in reducing exercise-induced hypoxemia in patients with COPD.

Interventions

DEVICEpulse oxygen supplementation devices

oxygen therapy delivered by systems using oxygen-saving valves

oxygen therapy delivered by continuous liquid oxygen devices

Sponsors

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* COPD on necessity of long term oxygen therapy * Able to give their written consent

Exclusion criteria

* Unstable patients with COPD * Patients with restrictive respiratory disease * Patients with cardiac or neurologic disease contre-indicating the different evaluations

Design outcomes

Primary

MeasureTime frame
oxygen saturation during 6 minutes walking test1 day

Secondary

MeasureTime frame
Walking distance during the 6 minutes walking test1 day

Countries

France

Contacts

Primary ContactBoris MELLONI, Pr
melloni@unilim.fr+33 1. 56. 81. 40. 60

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026